Correlation Between Sprott Physical and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Sprott Physical and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprott Physical and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprott Physical Gold and Big Pharma Split, you can compare the effects of market volatilities on Sprott Physical and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprott Physical with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprott Physical and Big Pharma.
Diversification Opportunities for Sprott Physical and Big Pharma
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sprott and Big is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Sprott Physical Gold and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Sprott Physical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprott Physical Gold are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Sprott Physical i.e., Sprott Physical and Big Pharma go up and down completely randomly.
Pair Corralation between Sprott Physical and Big Pharma
Assuming the 90 days trading horizon Sprott Physical Gold is expected to generate 0.81 times more return on investment than Big Pharma. However, Sprott Physical Gold is 1.23 times less risky than Big Pharma. It trades about 0.15 of its potential returns per unit of risk. Big Pharma Split is currently generating about 0.03 per unit of risk. If you would invest 2,086 in Sprott Physical Gold on September 4, 2024 and sell it today you would earn a total of 768.00 from holding Sprott Physical Gold or generate 36.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sprott Physical Gold vs. Big Pharma Split
Performance |
| Timeline |
| Sprott Physical Gold |
| Big Pharma Split |
Sprott Physical and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprott Physical and Big Pharma
The main advantage of trading using opposite Sprott Physical and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprott Physical position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Sprott Physical vs. Sprott Physical Silver | Sprott Physical vs. Sprott Physical Gold | Sprott Physical vs. Sprott Physical Platinum | Sprott Physical vs. Sprott Physical Uranium |
| Big Pharma vs. Sustainable Power Infrastructure | Big Pharma vs. Global Dividend Growth | Big Pharma vs. Brompton Lifeco Split | Big Pharma vs. Prime Dividend Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |